The Stanford Semen in IBD Men on Biologics and Advanced Therapies (SIMBA) Study
Published: 04/12/2022
General Information:
To understand important effects of inflammatory bowel disease and its treatments on male reproductive health and fertility
Eligibility:
Inclusion: Male aged 18-50 with IBD
Exclusion: Prior vasectomy, active testosterone or methotrexate usage
Study Details:
Study description/explanation of participation:
Our study is exploring important questions of male reproductive health in people with ulcerative colitis and Crohn's disease, including the effects of IBD medications on fertility. Participation is straightforward: all men complete an online questionnaire, submit a blood/stool sample, and submit a semen sample at our Stanford fertility center in Sunnyvale. For participants starting a new therapy for IBD, we would also like to collect follow-up semen samples three months after starting the therapy; all results will be shared with participants.
For complaints, concerns, or participant’s right questions, contact 1-866-680-2906